Efficacy of initial dose botulinum toxin A injection in acute concomitant esotropia with different clinical characteristics
Chin Med J (Engl)
.
2023 Sep 20;136(18):2249-2250.
doi: 10.1097/CM9.0000000000002728.
Epub 2023 May 26.
Authors
Ying Wang
1
2
,
Lijuan Lang
1
2
,
Jiong Zhang
1
2
,
Limin Xu
1
2
,
Junbo Rong
1
2
,
Kexin Guo
1
2
,
Luxi Zhang
1
2
,
Zhigang Li
1
2
,
Guangying Zheng
1
2
Affiliations
1
Department of Ophthalmic Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
2
Henan Engineering Research Center for Vision Screening and Prevention in Children, Zhengzhou, Henan 450000, China.
PMID:
37232466
PMCID:
PMC10508433
DOI:
10.1097/CM9.0000000000002728
No abstract available
MeSH terms
Botulinum Toxins, Type A* / therapeutic use
Esotropia* / drug therapy
Humans
Injections
Neuromuscular Agents*
Oculomotor Muscles
Treatment Outcome
Substances
Botulinum Toxins, Type A
Neuromuscular Agents